中神经递质受体的微RNA介导调节:系统性审查
Shivani Sonawane1, Vít Všianský2, Milan Brázdil1
1Brno Epilepsy Center, 1st Department of Neurology, Faculty of Medicine, Masaryk University and St. Annés University Hospital, Brno, Czech Republic; Behavioural and Social Neuroscience Research Group, CEITEC - Central European Institute of Technology Masaryk University, Brno, Czech Republic.
Epilepsy & behavior : E&B
|June 26, 2024
概括
微RNAs (miRNAs) 调节中的神经递质受体,提供潜在的临床应用. 本综述总结了关于神经元刺激性的miRNA介导控制的当前知识.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 的发病包括神经递质系统的调节失调,导致神经元过度兴奋.
- 微RNAs (miRNAs) 是转录后基因表达的关键调节者.
研究的目的:
- 对中神经递质受体的miRNA介导调节进行审查.
- 突出miRNAs在治疗中的潜在临床应用.
主要方法:
- 按照PRISMA指南进行系统审查.
- 使用关键词进行全面的文献搜索:,microRNA,神经递质和神经递质受体.
- 从已识别的研究文章提取数据.
主要成果:
- 在审查了724篇文章后,包括了17项研究.
- 大多数研究都集中在谷氨酸和GABA受体上.
- 一些研究研究了影响胆性,纯性和甘氨酸受体的miRNAs.
结论:
- 本综述巩固了目前关于miRNA在相关神经递质受体调节中的作用的理解.
- 鉴定的miRNAs代表了的潜在治疗标.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
285
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
285
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
Antiepileptic Drugs: Glutamate Antagonists
317
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
317
Neurochemical Transmission: Sites of Drug Action
2.2K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.2K
Arteries of the Lower Limbs
186
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
186
Excitatory and Inhibitory Effects of Neurotransmitters
9.9K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
9.9K


